The advantage of the ribozyme is that it can efficiently knock down wild-type PDEγ mRNA in vivo, reducing the target RNA and leading to a loss in rod photoreceptors and in rod-mediated ERG amplitudes, thus generating an animal model of retinal degeneration resembling human RP in an essentially normal adult retina. This evidence concerns the gene PDE6G and retinal degeneration.